Celldex Therapeutics Inc.

(NASDAQ:CLDX) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.

Contact Information

Website: www.celldex.com
Email: ir@celldextherapeutics.com
Main Phone: +1 908 200-7500
Address: 53 Frontage Road
Address 2: Suite 220
State: NJ
City / Town: Hampton
Country: US
Postal Code: 08827

Issuer Information

Exchange: NSC
CEO: Anthony S. Marucci
Employees: 125
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A